Effects of Exercise on Functional Dyspepsia Based on Rome IV

Functional Dyspepsia Clinical Trial

Official title:

Effects of Exercise on Patients With Functional Dyspepsia Based on Rome IV Criteria

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04540549
• Other study ID #: 2020031
• Status: Recruiting
• Phase: N/A
• Start date: September 1, 2020
• Est. completion date: August 31, 2021

Study information

• Verified date: September 2020
• Source: Second Affiliated Hospital of Xi'an Jiaotong University
• Contact: Jinhai Wang, MD
• Phone: +86-29-87679335
• Email: jinhaiwang[@]hotmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice. Functional dyspepsia is a clinical syndrome characterized by chronic and recurrent gastroduodenal symptoms in the absence of any organic or metabolic disease that is likely to explain the symptoms. Functional dyspepsia has a high incidence in the population. A recent research showed that FD is present in 11% of the Italian general population. It dramatically reduces a patient's quality of life, with an economic impact due to frequent clinical consultations, medication, and time off work. Although some experts recommend exercise as a first-line treatment for functional dyspepsia, there is little data on the relationship between exercise and functional dyspepsia, which needs to be confirmed by further research. Investigators designed this randomized controlled study to assess the effect of exercise on patients with functional dyspepsia based on Rome IV criteria.

Description:

Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice. Functional dyspepsia is a clinical syndrome characterized by chronic and recurrent gastroduodenal symptoms in the absence of any organic or metabolic disease that is likely to explain the symptoms. Functional dyspepsia has a high incidence in the population. A recent research showed that FD is present in 11% of the Italian general population. It dramatically reduces a patient's quality of life, with an economic impact due to frequent clinical consultations, medication, and time off work.

Regular physical activity and exercise may be a way of life to reduce low levels of inflammation throughout the body, thereby reducing the risk of developing chronic diseases. Multiple studies have shown that after regular exercise, markers of inflammation and oxidative stress are reduced, while markers of inflammation and antioxidants are increased, reflecting the anti-inflammatory and antioxidant properties of exercise.

Rome IV was introduced in 2016. Rome IV introduced more precisely define the minimal thresholds for frequency and severity of each individual symptom, primarily for scientific purposes, but data still need to be collected to define thresholds based on the frequency and/or severity of symptoms that impair quality of life.

Although some experts recommend exercise as a first-line treatment for functional dyspepsia, there is little data on the relationship between exercise and functional dyspepsia, which needs to be confirmed by further research. Investigators designed this randomized controlled study to assess the effect of exercise on patients with functional dyspepsia based on Rome IV criteria.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 260
• Est. completion date: August 31, 2021
• Est. primary completion date: August 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

1. Age =18 years old

2. Functional dyspepsia meeting Rome IV criteria

3. Gastroscope, blood routine, liver function and Hp examination were performed within the last year, and the results were normal

4. No prokinetic drug, proton pump inhibitor or mucosal protective agent was used in the last two weeks

5. Sign informed consent and be willing to participate in this study

Exclusion Criteria:

1. There are organic diseases that may explain the symptoms, such as peptic ulcer, gastrointestinal neoplasms, history of hepatobiliary and pancreatic diseases, history of tumor diseases, and history of metabolic diseases

2. Pregnancy, prepregnancy, or lactation

3. History of abdominal surgery

4. Mental illness

5. Severe impairment of heart, liver, or kidney function or respiratory function

6. Recent use of antidepressant, hormone, NSAIDs

7. The main symptoms are gastroesophageal reflux disease or irritable bowel syndrome

8. Failure to increase exercise levels

Related Conditions & MeSH terms

• Dyspepsia
• Functional Dyspepsia

Intervention

Behavioral:
• exercise
Jogging or cycling =5 days/week, 30-60 min/d

Locations

Country	Name	City	State
China	The Second Affiliated Hospital of Xi'an Jiaotong University	Xi'an

Sponsors (1)

Lead Sponsor	Collaborator
Second Affiliated Hospital of Xi'an Jiaotong University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Weekly global symptom assessment	Patients are asked to answer the following yes/no question once a week: "In the past 7 days, have you had adequate relief of your stomach symptoms?"	12 weeks
Secondary	Eight items of dyspepsia symptom score questionnaire(epigastric pain, epigastric burning, postprandial fullness, early satiety, belching, bloating, nausea, and vomiting)	severity(0=absent; 1=mild; 2=moderate); frequency (1 = less than once per week; 2 = once per week; 3 = two to three times per week; 4 = four to five times per week; 5 = daily); 3=severe and interfering with daily activities	12 weeks